Literature DB >> 12079900

Rheumatoid factor measured by fluoroimmunoassay: a responsive measure of rheumatoid arthritis disease activity that is associated with joint damage.

E Knijff-Dutmer1, W Drossaers-Bakker, A Verhoeven, G van der Sluijs Veer, M Boers, S van der Linden, M van de Laar.   

Abstract

OBJECTIVES: To determine whether rheumatoid factors (RFs), measured as continuous variables by time resolved fluoroimmunoassay, reflect disease activity in rheumatoid arthritis (RA). Further, to study the association of RFs and other disease activity parameters with radiological joint damage, especially in individual patients.
METHODS: In active, early RA, IgM and IgA RFs, as well as erythrocyte sedimentation rate (ESR), C reactive protein (CRP), tender joint score, and swollen joint score were assessed regularly. At the study start and at 56 and 80 weeks, radiographs of hands and feet were assessed by the Sharp score (van der Heijde modification). Associations between RFs and disease activity parameters were studied. In addition, associations between radiographic damage and disease activity parameters (baseline and time integrated) were analysed by non-parametric tests and multiple regression analysis. The relation between time integrated disease activity parameters and radiological damage in individual patients was analysed and visualised.
RESULTS: 155 patients were included. RF levels were strongly associated with the disease activity parameters (especially ESR and CRP) and with each other. All disease activity parameters, at baseline as well as time integrated parameters, were associated with (the progression of) radiographic damage. Moreover, in individual patients, a linear relationship between time integrated disease activity parameters and progression of radiological damage was seen.
CONCLUSION: RFs, measured as continuous variables, can be considered as disease activity parameters in patients with RA. The level of RF at baseline and the exposure to RF over time is associated with radiological damage. In individual patients, there is a constant relation between disease activity and radiological damage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079900      PMCID: PMC1754168          DOI: 10.1136/ard.61.7.603

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

1.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

2.  Disease activity and joint damage progression in early rheumatoid arthritis: relation to IgG, IgA, and IgM rheumatoid factor.

Authors:  K B Eberhardt; L Truedsson; H Pettersson; B Svensson; L Stigsson; J L Eberhardt; F A Wollheim
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

3.  A time-resolved fluoroimmuno assay of the IgM-rheumatoid factor.

Authors:  G van der Sluijs Veer; J W Soons
Journal:  Eur J Clin Chem Clin Biochem       Date:  1992-05

4.  Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis.

Authors:  D M van der Heijde; P L van Riel; I H Nuver-Zwart; F W Gribnau; L B vad de Putte
Journal:  Lancet       Date:  1989-05-13       Impact factor: 79.321

5.  Significance of rheumatoid factor isotypes in seronegative rheumatoid arthritis.

Authors:  F Eggelmeijer; H G Otten; H H de Rooy; M R Daha; F C Breedveld
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

6.  IgA and IgM rheumatoid factors as markers of later erosive changes in rheumatoid arthritis (RA).

Authors:  H Winska Wiloch; K Thompson; A Young; M Corbett; M Shipley; F Hay
Journal:  Scand J Rheumatol Suppl       Date:  1988

7.  Isotype-specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis.

Authors:  A Tarkowski; L A Nilsson
Journal:  J Clin Lab Immunol       Date:  1983-11

8.  IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis.

Authors:  M Gioud-Paquet; M Auvinet; T Raffin; P Girard; M Bouvier; E Lejeune; J C Monier
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

9.  Correlation of serum IgA rheumatoid factor levels with disease severity in rheumatoid arthritis.

Authors:  S Päi; L Päi; R Birkenfeldt
Journal:  Scand J Rheumatol       Date:  1998       Impact factor: 3.641

10.  Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study.

Authors:  D van Zeben; J M Hazes; A H Zwinderman; A Cats; E A van der Voort; F C Breedveld
Journal:  Ann Rheum Dis       Date:  1992-09       Impact factor: 19.103

View more
  11 in total

1.  Microfluidic-based measurement of erythrocyte sedimentation rate for biophysical assessment of blood in an in vivo malaria-infected mouse.

Authors:  Yang Jun Kang; Young-Ran Ha; Sang-Joon Lee
Journal:  Biomicrofluidics       Date:  2014-08-05       Impact factor: 2.800

2.  Diagnostic value and clinical significance of anti-CCP in patients with advanced rheumatoid arthritis.

Authors:  Nehir Samanci; Sebahat Ozdem; Halide Akbas; Derya Mutlu; Meral Gultekin; Mehmet Arman; Levent Donmez
Journal:  J Natl Med Assoc       Date:  2005-08       Impact factor: 1.798

3.  Radiographic estimation in seropositive and seronegative rheumatoid arthritis.

Authors:  Vjollca Sahatçiu-Meka; Sylejman Rexhepi; Suzana Manxhuka-Kërliu; Mjellma Rexhepi
Journal:  Bosn J Basic Med Sci       Date:  2011-08       Impact factor: 3.363

4.  Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis.

Authors:  C Turesson; L T H Jacobsson; G Sturfelt; E L Matteson; L Mathsson; J Rönnelid
Journal:  Ann Rheum Dis       Date:  2006-08-10       Impact factor: 19.103

5.  A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up.

Authors:  S M M Verstappen; G A van Albada-Kuipers; J W J Bijlsma; A A M Blaauw; Y Schenk; H C M Haanen; J W G Jacobs
Journal:  Ann Rheum Dis       Date:  2004-05-06       Impact factor: 19.103

6.  Precursor miR-499a Variant but not miR-196a2 is Associated with Rheumatoid Arthritis Susceptibility in an Egyptian Population.

Authors:  Eman A Toraih; Nesreen M Ismail; Ahmed A Toraih; Mohammad H Hussein; Manal S Fawzy
Journal:  Mol Diagn Ther       Date:  2016-06       Impact factor: 4.074

7.  Relationship between time-integrated disease activity estimated by DAS28-CRP and radiographic progression of anatomical damage in patients with early rheumatoid arthritis.

Authors:  Fausto Salaffi; Marina Carotti; Alessandro Ciapetti; Stefania Gasparini; Emilio Filippucci; Walter Grassi
Journal:  BMC Musculoskelet Disord       Date:  2011-05-30       Impact factor: 2.362

8.  The contribution of four immunogenetic markers for predicting persistent activity in patients with recent-onset rheumatoid arthritis or undifferentiated arthritis.

Authors:  Sonsoles Reneses; Antonio Fernández-Suárez; Maria F González-Escribano; Luis Pestana; Alicia García
Journal:  ISRN Rheumatol       Date:  2011-08-08

9.  OX40 signaling is involved in the autoactivation of CD4+CD28- T cells and contributes to the pathogenesis of autoimmune arthritis.

Authors:  Juean Jiang; Cuiping Liu; Mi Liu; Yu Shen; Xiaohan Hu; Qin Wang; Jian Wu; Min Wu; Qi Fang; Xueguang Zhang
Journal:  Arthritis Res Ther       Date:  2017-03-21       Impact factor: 5.156

10.  Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems.

Authors:  Jennie Ursum; Wouter H Bos; Rob J van de Stadt; Ben A C Dijkmans; Dirkjan van Schaardenburg
Journal:  Arthritis Res Ther       Date:  2009-05-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.